KCTD10 Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9H3F6 |
---|---|
Clone Names | 100406025 |
Gene ID | 83892 |
---|---|
Other Names | BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3, hBACURD3, BTB/POZ domain-containing protein KCTD10, Potassium channel tetramerization domain-containing protein 10, KCTD10, ULR061 |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13390b was selected from the C-term region of KCTD10. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | KCTD10 |
---|---|
Synonyms | ULR061 |
Function | Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex. The BCR(BACURD3) E3 ubiquitin ligase complex mediates the ubiquitination of target proteins, leading to their degradation by the proteasome (By similarity). |
Cellular Location | Nucleus. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex. The BCR(BACURD3) E3 ubiquitin ligase complex mediates the ubiquitination of target proteins, leading to their degradation by the proteasome (By similarity).
References
Keebler, M.E., et al. Circ Cardiovasc Genet 3(4):358-364(2010)Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Junyent, M., et al. Am. J. Clin. Nutr. 90(3):686-694(2009)Wang, Y., et al. J. Cell. Biochem. 106(3):409-413(2009)Liu, R., et al. FEBS J. 276(4):1114-1124(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.